This blog is to share the latest research and development of acupuncture and raise the awareness of alternative treatments for your conditions, and is for information only.

Monday 19 September 2016

Acupuncture improved MCI in patients with post-cerebral infarction

Acupuncture in combination with nimodipine showed a sustainable improvement of cognitive function in patients with post-cerebral infarction. It was reported in journal of BMC Complementary and Alternative Medicine.

Patients with cerebral vascular disease such as stroke often develop cognitive dysfunction ranging from mild cognitive impairment (MCI) to dementia. It was reported that nearly 50% of patients developed MCI within four years after stroke. Clinical studies showed that cholinesterase inhibitors donepezil, galantamine, and rivastigmine produced some beneficial effect in patients with MCI. However none of them was approved for the treatment of vascular cognitive impairment due to the uncertain effect of drugs. Acupuncture has been used to treat cognitive impairment in China for a long time.

Dr. S Wang and colleagues in China conducted a randomized clinical study to assess the efficacy and safety of acupuncture alone or in combination with nimodipine to treat cerebral infarction-induced MCI. A total of 126 patients with post-cerebral infarction MCI were recruited and randomly divided into 3 groups, nimodipine alon group (30 mg/time and 3 times daily), acupuncture alone group and acupuncture combined nimodipine group. Patients were assessed with Montreal Cognitive Assessment (MoCA) scale before treatment, at the end of 3-month treatment and post-treat 3-month follow-up. Acupuncture stimulation was manually applied at following acupoints: DU20, EX-HN1, ST2, GB20, GB12, BL10, DU26, HT7, PC6, ST40, SP6 and LR3, 30 min each time, 6 times a week for 3 months.

At the end of study, all three treatment groups showed a significant improvement judged by MoCA scale compared with respective baseline; however, the significant improvement was markedly higher in combination group compared nimodipine alone and acupuncture alone group. Further, at the 3-month follow-up the sustained improvement was more significant in combination group compared other two groups. No adverse effect was reported with three groups at the end of study.

The study suggested that acupuncture could be used as an adjunct therapy to drug treatment to further improve cognitive function in patients with post-infarction.

Reference:
S Wang et al., Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complementary and Alternative Medicine (2016) 16:361.   http://www.ncbi.nlm.nih.gov/pubmed/27623621